RecruitingNCT06297993
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
Studying Primary sclerosing cholangitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- PSC Partners Seeking a Cure
- Principal Investigator
- Cynthia Levy, MDUniversity of Miami
- Enrollment
- 2000 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2024 – 2031
Study locations (16)
- UC Davis, Sacramento, California, United States
- California Pacific Medical Center, San Francisco, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Yale University, New Haven, Connecticut, United States
- Schiff Center for Liver Diseases / University of Miami, Miami, Florida, United States
- Indiana University, Indianapolis, Indiana, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Virginia Commonwealth University, Richmond, Virginia, United States
- University of Alberta, Edmonton, Alberta, Canada
- University Health Network, Toronto, Ontario, Canada
- Centre de recherche du centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada
- University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg, Germany
- University of Milano Bicocca, Milan, Monza (MB), Italy
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06297993 on ClinicalTrials.govOther trials for Primary sclerosing cholangitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07229911A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)Takeda
- RECRUITINGPHASE2NCT06699121A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSCLISCure Biosciences
- RECRUITINGPHASE2NCT06905054Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver TransplantationMayo Clinic
- RECRUITINGNANCT06865924Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing CholangitisFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- RECRUITINGNANCT06351696The Effects of Bromelain Supplement in Patients With Ulcerative ColitisNational Nutrition and Food Technology Institute
- RECRUITINGPHASE2NCT06286709FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitisUniversity of Birmingham
- RECRUITINGEARLY PHASE1NCT06197308Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSCUniversity of Minnesota
- RECRUITINGPHASE2NCT05835505Detoxification of the Liver In PSC (Dolphin)Brigham and Women's Hospital